Back to top
more

Research Frontiers (REFR)

(Delayed Data from NSDQ)

$1.59 USD

1.59
89,343

-0.02 (-1.24%)

Updated Apr 26, 2024 03:59 PM ET

After-Market: $1.59 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (143 out of 252)

Industry: Electronics - Miscellaneous Products

Better trading starts here.

Zacks News

Research Frontiers (REFR) Reports Q3 Loss, Misses Revenue Estimates

Research Frontiers (REFR) delivered earnings and revenue surprises of -100.00% and -28.00%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Research Frontiers (REFR) Q3 Earnings Preview: What to Look Out For

Research Frontiers (REFR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Research Frontiers (REFR) is a Great Momentum Stock

Does Research Frontiers (REFR) have what it takes to be a top stock pick for momentum investors? Let's find out.

    Has Research Frontiers (REFR) Outpaced Other Computer and Technology Stocks This Year?

    Is (REFR) Outperforming Other Computer and Technology Stocks This Year?

      Has Research Frontiers (REFR) Outpaced Other Computer and Technology Stocks This Year?

      Is (REFR) Outperforming Other Computer and Technology Stocks This Year?

        Why Look for Bargain Hunting? Bet on 5 Stocks with Rising P/E

        Cross the age-old barrier of low P/E investing, bet on these five stocks that boast rising P/E.

          Use Rising P/E Tactic to Find Out 5 Winning Stocks

          Cross the age-old barrier of low P/E investing, bet on these five stocks that boast a rising P/E.

            Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma

            Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma